Annual Drug Patent Expirations for SPRITAM
Spritam is a drug marketed by Aprecia Pharms and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has nineteen patent family members in nine countries.
The generic ingredient in SPRITAM is levetiracetam. One supplier is listed for this compound. Additional details are available on the levetiracetam profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com